Frontlight ResearchEarly access
Active, not recruitingNo phase
Utility of a Mindfulness App for Outpatients Awaiting Appointments for Mental Health Interventions
Key facts
- Who runs it
- Institute of Mental Health, Singapore
- Where
- Singapore1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Active, not recruiting
- People taking part
- 122 people, planned
- Started
- 1 Feb 2025
- Expected to end
- 31 Dec 2026
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Mobile App - AmDTx (New name DawnDTx)
- Placebo App
- Record updated
- 21 August 2026
Who can take part
- Age
- 13 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 9 criteriaShow less
Who can take part
- -Waitlisted for outpatient psychosocial programming or psychiatric services at IMH or SGH
- Age range: IMH: 13 and above; SGH: 21 and above
- Language: Fluency in English (to complete assessments)
- Understanding and willingness to comply with study requirements / capable of providing informed consent (e.g., autonomously or with guardian support)
- Comfortable with smartphone or tablet, downloading and running the AmDTx platform, and at least periodic access to the internet
Who cannot take part
- Serious medical condition that precludes participation in this study
- Any known practical factors that would preclude participation (e.g., extended absences) in the study
- Intellectual disability (as evidenced by attending a special school for intellectual disability)
- Participation in another treatment/intervention study
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
Randomized Control Trial of AmDTx (new name DawnDTx) on waitlist patients waiting for first psychiatric consultation to determine if a digital mental health app can reduce PHQ8 and GAD7 scores during the waitlist period.
The 2 groups in the trial
- Active AppExisting treatment, for comparison
Actual AmDTx App
Treatment: Mobile App - AmDTx (New name DawnDTx)
- PlaceboPlacebo, for comparison
Placebo App
Treatment: Placebo App
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Record updated
- 21 August 2026